![]() Cogent Biosciences Cogent Biosciences (formerly known as Unum Therapeutics) is a biotechnology company that designs precision therapies to treat genetically driven diseases. | ![]() Orchard Therapeutics Orchard Therapeutics is a biotechnology company that develops transformative ex vivo autologous hematopoietic stem cell gene therapy. | ![]() Stealth BioTherapeutics Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction. | ![]() Ambys Medicines Ambys Medicines is a developer of regenerative medicine therapies for serious liver diseases. | |
Founding Date | Founding Date 2014 | Founding Date 2015 | Founding Date 2007 | Founding Date 2018 |
Type | Type Public | Type Subsidiary | Type Public | Type Private |
Tags | ||||
Locations | Locations Waltham, US HQ Boulder, US | Locations London, GB HQ Boston, US Boston, US Foster City, US Menlo Park, US | Locations Newton, US HQ Needham, US | Locations Redwood City, US HQ South San Francisco, US |
Employees | Employees 25826% increase | Employees 166 | Employees 592% decrease | Employees 14 |
Valuation ($) | Valuation ($) 1.3 b | Valuation ($) N/A | Valuation ($) 18.4 m | Valuation ($) N/A |
Financial | ||||
Net income | Net income ($328.9m) (FY, 2025) | Net income ($150.7m) (FY, 2022) | Net income ($52.5m) (FY, 2021) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 178.3m | Total funding raised $ 310.7m | Total funding raised $ 100m | Total funding raised $ 140m |

Orchard Therapeutics is a biotechnology company that develops transformative ex vivo autologous hematopoietic stem cell gene therapy.
View company
Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction.
View company
Ambys Medicines is a developer of regenerative medicine therapies for serious liver diseases.
View company